secwatch.observer — SEC 8-K summary
======================================

Issuer:     CytomX Therapeutics, Inc. (CTMX)
CIK:        0001501989
Form:       8-K
Filed at:   2022-04-14T23:59:59+00:00
Accession:  0001193125-22-105580
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CytomX director John A. Scarlett to retire at June 15, 2022 annual meeting
--------------------------------------------------------------------------

- John A. Scarlett, M.D. informed CytomX of his retirement from the board, effective at the next annual meeting on June 15, 2022.
- Dr. Scarlett's retirement is not the result of any dispute or disagreement with the company.
- The retirement is a planned departure at the end of his current term.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501989/000119312522105580/0001193125-22-105580-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501989/000119312522105580/d334476d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-105580

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer